Clinical trial · Observational
Epidemiologic Registry PETHEMA LMA 2013
Epidemiologic Registry of Patients Diagnosed With Acute Myeloid Leukemia (PETHEMA LMA 2013)
NCT02006004CI-TRIAL-00019460completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Epidemiologic and retrospective multicenter registry of all patients diagnosed with de novo or secondary AML in the PETHEMA Group institutions. This study is a non-interventional research regarding diagnosis and therapeutic approach
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| AML | Acute Myeloid Leukemia | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Characteristics of the patients diagnosed with AML
- timeFrame
- 3 years
- description
- To realize an epidemiologic and retrospective study to assess the characteristics of the patients diagnosed with AML and their disease, regardless the age or treatment
Secondary outcomes (2)
- measure
- Prognosis factors
- timeFrame
- 3 years
- description
- To correlate clinical and biological features with outcome and evolution of the patients.
- measure
- Risk factors
- timeFrame
- 3 years
- description
- To identify and confirm the risk factors which are involved in the evolution of the disease.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Patients diagnosed with acute myeloid leukemia Exclusion Criteria: no exclusion criteria
References
Publications (0)
Data not yet available
No reference posted for this study.